Ambu

Rising Costs, Stricter Rules And Rivals Will Limit Market Prospects

AnalystLowTarget

Not Invested

Consensus Narrative from 7 Analysts

Published

02 Jul 25

AnalystLowTarget's Fair Value

DKK 94.54

2.4% overvalued

27 Aug

DKK 96.80

-27.3%

0.05%

-27.3%

0.05%

Edit anytime before Jul 2 10:17 PM. Then post Updates to your followers.

Author's Valuation

DKK 94.5

2.4% overvalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

DKK 94.5

2.4% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

10.61%

Medical Equipment revenue growth rate

0.39%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

5.51%

Calculation

DKK 1.19b

Earnings '28

25.15x

PE Ratio '28

DKK 29.94b

Market Cap '28

DKK 29.94b

Market Cap '28

270.42m

No. shares '28

DKK 110.70

Share Price '28

DKK 110.70 Share Price '28

Discounted to 2025 @ 5.59% p.a.

DKK 94.04

Fair Value '25